NEW YORK, NY–(Marketwired – June 06, 2016) – The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Endo International plc (“Endo” or the “Company”) (NASDAQ: ENDP) between March 2, 2015 and May 6, 2016. You are hereby notified that a securities class action has commenced in the USDC for the Southern District of New York. To get more information go to: http://www.zlk.com/pslra/endo-international.

Endo’s revenue stream relies in part on its ability to negotiate favorable arrangements with pharmacy benefit managers (“PBMs”) for the coverage of the Company’s products by insurers. The complaint alleges that throughout the class period, defendants made materially false and/or misleading statements and/or failed to disclose that: (a) its subsidiary, Endo Pharmaceuticals Inc., had arrangements with PBMs with respect to the migraine therapy Frova which included questionable incentives intended to increase sales revenues; and (b) as a result, Endo’s revenues and revenue projections relied in part on unsustainable arrangements.

On May 6, 2016, Endo stock fell nearly 40% after slashing its full-year revenue and profit forecasts. The company also announced that in March of 2016, Endo Pharmaceuticals had received a request for documents from the U.S. Attorney’s Office for the Southern District of New York “regarding contracts with Pharmacy Benefit Managers regarding [the migraine treatment] Frova.”

If you suffered a loss in Endo you have until July 25, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/pslra/endo-international.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
30 Broad Street – 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com